Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.20.4
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of changes in derivative liability

The following presents changes in the derivative liability through September 30, 2020:

 

    Nine Months Ended   Nine Months Ended
    September 30, 2020   September 30, 2019
Beginning Balance   $ 24,767,000     $ 11,917,000  
Conversion to note payable     (19,291,000 )        
Change in fair value recognized in earnings     (5,476,000 )     2,213,000  
 Ending Balance   $ —       $ 14,130,000  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table presents: 1) instruments that were dilutive for the quarter ended September 30, 2019 were included in the diluted earnings per share, and 2) instruments that were anti-dilutive for the quarter ended September 30, 2020 and the nine months ended September 30, 2020 and 2019 were excluded from diluted earnings per share as they would have been antidilutive:

 

    Three Months Ended September 30, 2020   Three Months Ended September 30, 2019   Nine Months Ended September 30, 2020   Nine Months Ended September 30, 2019
Convertible notes and accrued interest     102,141,642       97,510,202       102,141,642       97,510,202  
Convertible preferred stock - Series B     11,818,181       11,818,181       11,818,181       11,818,181  
Compensation-based stock options and warrants     193,177,143       193,177,143       193,177,143       196,027,315